Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Lymphoma

Autologous stem cell transplantation in adult patients with peripheral T-cell lymphoma: a nation-wide survey

Bone Marrow Transplantation volume 33, pages 405–410 (2004)Cite this article

Summary:

Limited experience is available on the feasibility and efficacy of high-dose therapy (HDT) supported by autologous stem cell transplantation (ASCT) in patients with peripheral T-cell lymphoma (PTCL). Therefore, a nation-wide survey was conducted in adult patients transplanted for PTCL in Finland during 1990–2001. After histopathology review, 37 patients were identified. The median age was 46 years (16–68) at the time of ASCT. Histology included PTCL not otherwise specified in 14 patients, anaplastic large cell lymphoma (ALCL) in 14 patients, and other in nine patients. Disease status at the time of ASCT was CR/PR1 in 18 patients; CR/PR2 in 14 patients, and other in five patients. HDT consisted of either BEAC (N=22) or BEAM (N=15), supported by blood stem cells in 34 patients (92%). Early transplant-related mortality was 11%. With a median follow-up of 24 months from HDT, 16 patients (43%) have relapsed or progressed. The estimated 5-year overall survival (OS) was 54%. Patients with ALCL had superior OS when compared with other subtypes (85 vs 35%, P=0.007). OS at 5 years was 63% in patients transplanted in CR/PR1 vs 45% in those transplanted in other disease status (P=NS). Prospective studies are needed to define the role of ASCT in this lymphoma type.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  1. Jaffe ES, Harris NL, Stein H, Vardiman JW . Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. World Health Organization Classification of Tumours. IARC Press, Lyon, 2001.

    Google Scholar 

  2. Armitage J, Vose J, Linder J et al. Clinical significance of immunophenotyping in diffuse aggressive non-Hodgkin's lymphoma. J Clin Oncol 1989; 7: 1783–1785.

    Article  CAS  Google Scholar 

  3. Coiffier B, Brousse N, Peuchmauer M et al. Peripheral T-cell lymphomas have a worse prognosis than B-cell lymphomas: a prospective study of 361 immunophenotyped patients treated with LNH-84 regimen. Ann Oncol 1990; 1: 45–50.

    Article  CAS  Google Scholar 

  4. Melnyk A, Rodriquez A, Pugh WC et al. Evaluation of the revised European–American Lymphoma classification confirms the clinical relevance of immunophenotype in 560 cases of aggressive non-Hodgkin's lymphoma. Blood 1997; 89: 4514–4520.

    CAS  Google Scholar 

  5. Gisselbrecht C, Gaulard P, Lepage E et al. Prognostic significance of T-cell phenotype in aggressive non-Hodgkin's lymphoma. Groupe d' Etudes des Lymphomes de l'Adulte (GELA). Blood 1998; 92: 76–82.

    CAS  Google Scholar 

  6. Lopez-Guillermo A, Cid J, Salar A et al. Peripheral T-cell lymphomas: initial features, natural history, and prognostic factors in a series of 174 patients diagnosed according to the R.E.A.L. classification. Ann Oncol 1998; 9: 849–855.

    Article  CAS  Google Scholar 

  7. Ansell SM, Habermann TM, Kurtin PJ et al. Predictive capacity of the International Prognostic Factor Index in patients with peripheral T-cell lymphoma. J Clin Oncol 1997; 15: 2296–2301.

    Article  CAS  Google Scholar 

  8. Armitage JO, Weisenburger DD . New approach to classifying non-Hodgkin's lymphomas: clinical features of the major histologic types. Non-Hodgkin's Lymphoma Classification Project. J Clin Oncol 1998; 16: 2780–2795.

    Article  CAS  Google Scholar 

  9. Fanin R, Silvestri F, Geromin A et al. Primary systemic CD30 (Ki-1)-positive anaplastic large cell lymphoma of the adult: sequential intensive treatment with the F-MACHOP regimen (+/−radiotherapy) and autologous bone marrow transplantation. Blood 1996; 87: 1243–1248.

    CAS  Google Scholar 

  10. Fanin R, Ruiz de Elvira MC, Sperotto A et al. Autologous stem cell transplantation for T and null cell CD30-positive anaplastic large cell lymphoma: analysis of 64 adult and paediatric cases reported to the European Group for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant 1999; 23: 437–442.

    Article  CAS  Google Scholar 

  11. Deconinck E, Lamy T, Foussard C et al. Autologous stem cell transplantation for anaplastic large-cell lymphomas: results of a prospective trial. Br J Haematol 2000; 109: 736–742.

    Article  CAS  Google Scholar 

  12. Vose JM, Peterson C, Bierman PJ et al. Comparison of high-dose therapy and autologous bone marrow transplantation for T-cell and B-cell non-Hodgkin's lymphomas. Blood 1990; 76: 424–431.

    CAS  Google Scholar 

  13. Blystad AK, Enblad G, Kvaloy S et al. High-dose therapy with autologous stem cell transplantation in patients with peripheral T cell lymphomas. Bone Marrow Transplant 2001; 27: 711–716.

    Article  CAS  Google Scholar 

  14. Rodriquez J, Munsell M, Yazji S et al. Impact of high-dose therapy on peripheral T-cell lymphomas. J Clin Oncol 2001; 19: 3766–3770.

    Article  Google Scholar 

  15. Kahl C, Leithauser M, Wolff D et al. Treatment of peripheral T-cell lymphomas (PTCL) with high-dose chemotherapy and autologous or allogeneic hematopoietic transplantation. Ann Hematol 2002; 81: 646–650.

    Article  CAS  Google Scholar 

  16. Song KW, Mollee P, Keating A, Crump M . Autologous stem cell transplant for relapsed and refractory peripheral T-cell lymphoma: variable outcome according to pathological subtype. Br J Haematol 2003; 120: 978–985.

    Article  Google Scholar 

  17. Harris NL, Jaffe E, Stein H et al. A revised European–American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994; 84: 1361–1392.

    CAS  PubMed Central  Google Scholar 

  18. Kaplan E, Meier P . Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 157–181.

    Article  Google Scholar 

  19. Jantunen E, Kuittinen T, Nousiainen T . Is chemotherapy scoring useful to predict progenitor cell mobilisation in patients with non-Hodgkin's lymphoma? Bone Marrow Transplant 2003; 32: 569–573.

    Article  CAS  Google Scholar 

  20. Kingreen D, Reichle A, Fetscher S et al. High dose chemotherapy with autologous stem cell transplant in patients with angioimmunoblastic T-cell lymphoma (AILD). Blood 1999; 94: 172a.

    Google Scholar 

  21. Oinonen R, Jantunen E, Itälä M et al. Autologous stem cell transplantation in patients with mantle cell lymphoma. Leuk Lymphoma 2002; 43: 1229–1237.

    Article  Google Scholar 

  22. Jantunen E, Kuittinen T, Nousiainen T . BEAC or BEAM for conditioning in patients with non-Hodgkin's lymphoma? A single centre analysis on toxicity and efficacy. Leuk Lymphoma 2003; 44: 1151–1158.

    Article  CAS  Google Scholar 

  23. Weisenburger DD, Anderson JR, Diebold J et al. Systemic anaplastic large-cell lymphoma: results from the non-Hodgkin's lymphoma classification project. Am J Hematol 2001; 67: 172–178.

    Article  CAS  Google Scholar 

  24. Falini B, Pileri S, Zinzani PL et al. ALK+ lymphoma: clinico-pathologic findings and outcome. Blood 1999; 93: 2697–2706.

    CAS  PubMed Central  Google Scholar 

  25. Falini B . Anaplastic large cell lymphoma: pathological, molecular and clinical features. Br J Haematol 2001; 114: 741–760.

    Article  CAS  Google Scholar 

  26. Gascoyne RD, Aoun P, Wu D et al. Prognostic significance of anaplastic lymphoma kinase (ALK) protein expression in adults with anaplastic large cell lymphoma. Blood 1999; 93: 3913–3921.

    CAS  PubMed Central  Google Scholar 

  27. Stein H, Foss H-D, Durkopp H et al. CD30+ anaplastic large cell lymphoma: a review of its histopathologic, genetic and clinical features. Blood 2000; 96: 3681–3695.

    CAS  Google Scholar 

  28. Vose JM, Bierman PJ, Anderson JR et al. Progressive disease after high-dose therapy and autologous transplantation for lymphoid malignancy: clinical course and patient follow-up. Blood 1992; 80: 2142–2148.

    CAS  Google Scholar 

  29. Johnsen HE, Björkstrand B, Carlson K et al. Outcome for patients with leukemia, multiple myeloma and lymphoma who relapse after high dose therapy and autologous stem cell support. Leuk Lymphoma 1996; 24: 81–91.

    Article  CAS  Google Scholar 

  30. Paltiel O, Rubinstein C, Or R et al. Factors associated with survival in patients with progressive disease following autologous transplant for lymphoma. Bone Marrow Transplant 2003; 31: 565–569.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Kuopio University Hospital, Kuopio, Finland

    E Jantunen & T Nousiainen

  2. Department of Oncology, Helsinki University Central Hospital, Helsinki, Finland

    T Wiklund & S Leppä

  3. Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland

    E Juvonen & E Elonen

  4. Department of Medicine, Turku University Central Hospital, Turku, Finland

    M Putkonen & K Remes

  5. Department of Oncology, Tampere University Hospital, Tampere, Finland

    T Lehtinen

  6. Department of Oncology, Oulu University Hospital, Oulu, Finland

    O Kuittinen

  7. Medix Laboratories, Espoo, Finland

    K Franssila

  8. Department of Pathology, University of Turku, Turku, Finland

    K-O Söderström

  9. Molecular Cancer Biology Research Program, Haartman Institute, University of Helsinki, Helsinki, Finland

    S Leppä

Authors
  1. E Jantunen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. T Wiklund
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. E Juvonen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M Putkonen
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. T Lehtinen
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. O Kuittinen
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. K Franssila
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. K-O Söderström
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. S Leppä
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. E Elonen
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. K Remes
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. T Nousiainen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to E Jantunen.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jantunen, E., Wiklund, T., Juvonen, E. et al. Autologous stem cell transplantation in adult patients with peripheral T-cell lymphoma: a nation-wide survey. Bone Marrow Transplant 33, 405–410 (2004). https://doi.org/10.1038/sj.bmt.1704367

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1704367

Keywords

This article is cited by

Search

Advanced search

Quick links